Pharmacological treatment for the Novel Coronavirus disease 2019 (COVID-19 Infection) N Tidwong, P Montakantikul, W Manosuthi Pharmaceutical Sciences Asia Review 47 (2), 97-103, 2020 | 5 | 2020 |
Optimized chloroquine phosphate dosage regimens for early virological clearance of severe acute respiratory syndrome coronavirus 2 using Monte Carlo simulation. N Tidwong, B Punyawudho, P Leelawattanachai, S Tangtrakultham, ... Pharmaceutical Sciences Asia 48 (3), 2021 | 2 | 2021 |
Antibiotic prescribing behavioral assessment of physicians involved in surgical care K Jantarathaneewat, S Chansirikarnjana, N Tidwong, LM Mundy, ... Infection Control & Hospital Epidemiology 40 (9), 1079-1081, 2019 | 2 | 2019 |
Optimized fosfomycin regimens for treating carbapenem‐resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function N Tidwong, A Chanruang, S Chupradit, SL Parker, P Leelawattanachai, ... Clinical and Translational Science 17 (10), e70038, 2024 | | 2024 |
Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019. K Koyratkoson, N Tidwong, S Tangtrakultham, P Montakantikul Pharmaceutical Sciences Asia 49 (4), 2022 | | 2022 |
Optimizing hydroxychloroquine dosing regimen for treatment of pediatric patients with coronavirus disease 2019 using Monte Carlo simulation. L Treerattanapun, S Tangtrakultham, N Tidwong, P Montakantikul Pharmaceutical Sciences Asia 49 (1), 2022 | | 2022 |
Current and Repurposing Medication for SARS-CoV-2 Infection K Jantarathaneewat, K Kangwantas, N Tidwong Asian Medical Journal and Alternative Medicine 21, S91-S101, 2021 | | 2021 |